Literature DB >> 743983

Conversion of L-thyroxine to triiodothyronine in rat kidney homogenate.

P Chiraseveenuprapund, U Buergi, A Goswami, I N Rosenberg.   

Abstract

Rat kidney homogenates, in phosphate-EDTA buffer, consistently catalyzed the formation of T3 from added L-thyroxine (T4). The formation of T3 was assessed by both paper chromatography and RIA of T3. Conversion of T4 to T3 appeared to be enzymatic, showing pH and temperature optima (pH 7.0 and 37 C, respectively) and tissue and time dependence. Formation of T3 was unaffected by azide, cyanide, or catalase, nor was it dependent upon oxygen; indeed, under anaerobic conditions conversion of T4 to T3 was enhanced. Dialyzed homogenate retained full activity, and no cofactor requirement was demonstrated. A role of iron and thiol groups in the enzymatic formation of T3 from T4 was suggested by the inhibitory action of iron chelators and thiol-blocking reagents. The capacity of kidney for T3 formation was considerable and increased with increasing T4 concentrations, being approximately 2 nmol/g tissue/h at very high T4 levels. The apparent Km was estimated to be 3 x 10(-6) M. The conversion of T4 to T3 was inhibited by propylthiouracil at micromolar concentrations whereas methimazole, iodide, and lithium salts were without effect. The enzymatic activity of the homogenates was associated with its particulate components, the readily sedimenting fractions corresponding to plasma membranes and mitochondria being most active, and was absent from nuclei and cytosol.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 743983     DOI: 10.1210/endo-102-2-612

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  11 in total

1.  Hepatic 5'-monodeiodinase activity in teleosts in vitro: A survey of thirty-three species.

Authors:  J F Leatherland; P K Reddy; A N Yong; A Leatherland; T J Lam
Journal:  Fish Physiol Biochem       Date:  1990-01       Impact factor: 2.794

2.  Phenolic and tyrosyl ring deiodination of iodothyronines in rat brain homogenates.

Authors:  M M Kaplan; K A Yaskoski
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

3.  Alterations in 3,3'5'-triiodothyronine metabolism in response to propylthiouracil, dexamethasone, and thyroxine administration in man.

Authors:  J S LoPresti; A Eigen; E Kaptein; K P Anderson; C A Spencer; J T Nicoloff
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

4.  Hormonal control of manganese transport in the mouse thyroid.

Authors:  M Nishida; J Kawada
Journal:  Experientia       Date:  1992-03-15

5.  Qualitative and quantitative differences in the pathways of extrathyroidal triiodothyronine generation between euthyroid and hypothyroid rats.

Authors:  J E Silva; M B Gordon; F R Crantz; J L Leonard; P R Larsen
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

6.  L-triiodothyronine and L-reverse-triiodothyronine generation in the human polymorphonuclear leukocyte.

Authors:  K A Woeber
Journal:  J Clin Invest       Date:  1978-09       Impact factor: 14.808

7.  Thyroid function in patients with acute renal failure.

Authors:  D Bodziony; F Kokot; S Czekalski
Journal:  Int Urol Nephrol       Date:  1981       Impact factor: 2.370

8.  Inhibition of rat hepatic thyroxine 5'-monodeiodinase by propylthiouracil: relation to site of interaction of thyroxine and glutathione.

Authors:  T Yamada; I J Chopra; N Kaplowitz
Journal:  J Endocrinol Invest       Date:  1981 Oct-Dec       Impact factor: 4.256

9.  The role of sulfhydryl groups on the impaired hepatic 3',3,5-triiodothyronine generation from thyroxine in the hypothyroid, starved, fetal, and neonatal rodent.

Authors:  A R Harris; S L Fang; L Hinerfeld; L E Braverman; A G Vagenakis
Journal:  J Clin Invest       Date:  1979-03       Impact factor: 14.808

10.  Properties of cytosolic components activating rat hepatic 5' [corrected]-deiodination in the presence of NADPH.

Authors:  K Sawada; B C Hummel; P G Walfish
Journal:  Biochem J       Date:  1986-03-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.